Repurposing old drugs as antiviral agents for coronaviruses

BACKGROUND: New therapeutic options to address the ongoing coronavirus disease 2019 (COVID-19) pandemic are urgently needed. One possible strategy is the repurposing of existing drugs approved for other indications as antiviral agents for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed J
Autors principals: Yang, Cheng-Wei, Peng, Tzu-Ting, Hsu, Hsing-Yu, Lee, Yue-Zhi, Wu, Szu-Huei, Lin, Wen-Hsing, Ke, Yi-Yu, Hsu, Tsu-An, Yeh, Teng-Kuang, Huang, Wen-Zheng, Lin, Jiunn-Horng, Sytwu, Huey-Kang, Chen, Chiung-Tong, Lee, Shiow-Ju
Format: Artigo
Idioma:Inglês
Publicat: Chang Gung University 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7245249/
https://ncbi.nlm.nih.gov/pubmed/32563698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bj.2020.05.003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars